📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Virion Serion

1.1 - Company Overview

Virion Serion Logo

Virion Serion

Headquarter: Germany
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of in-vitro diagnostic products for infectious disease detection—viral, bacterial, fungal, and parasitic—including classic tests recommended for quantified antibodies and products that allow simultaneous antibody detection against multiple antigens using flow cytometry.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Virion Serion

MaxThera Logo

MaxThera

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development of new treatments for bacterial infections, especially those caused by drug-resistant bacteria.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MaxThera company profile →
ProStrakan Logo

ProStrakan

HQ: United Kingdom Website
  • Description: Provider of specialty pharmaceutical development and commercialisation of prescription medicines for unmet therapeutic needs in major markets; headquartered in Scotland with more than 300 employees and commercial operations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProStrakan company profile →
Protez Pharmaceuticals Logo

Protez Pharmaceuticals

HQ: United States Website
  • Description: Provider of differentiated intravenous and oral small molecule antibiotics for difficult-to-treat hospital-based infections, addressing bacterial resistant and chronic or recurrent infections; discovers, develops, and commercializes antibiotic therapies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protez Pharmaceuticals company profile →
Bluejay Therapeutics Logo

Bluejay Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical drug candidates for infectious diseases, including BJT-778, a fully human IgG1 monoclonal antibody designed to neutralize and facilitate clearance of HDV virions, contributing to a potential functional cure for CHB/CHD, and BJT-628, an oral liver-targeted HBV transcript inhibitor reducing HBsAg. Offers the Bluejay L-TAP platform for liver-targeted oral delivery and runs Phase 1/2a trials in chronic hepatitis B.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bluejay Therapeutics company profile →
Anadys Pharmaceuticals Logo

Anadys Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics for chronic hepatitis C, developing ANA598, a direct-acting antiviral (DAA), and resuming clinical development of ANA773.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Anadys Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Virion Serion

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Virion Serion

2.2 - Growth funds investing in similar companies to Virion Serion

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Virion Serion

4.2 - Public trading comparable groups for Virion Serion

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Virion Serion

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Virion Serion

What does Virion Serion do?

Virion Serion is a provider of in-vitro diagnostic products for infectious disease detection—viral, bacterial, fungal, and parasitic—including classic tests recommended for quantified antibodies and products that allow simultaneous antibody detection against multiple antigens using flow cytometry.

Who are Virion Serion's competitors?

Virion Serion's competitors and similar companies include MaxThera, ProStrakan, Protez Pharmaceuticals, Bluejay Therapeutics, and Anadys Pharmaceuticals.

Where is Virion Serion headquartered?

Virion Serion is headquartered in Germany.

How many employees does Virion Serion have?

Virion Serion has 1,000 employees 🔒.

When was Virion Serion founded?

Virion Serion was founded in 2010 🔒.

What sector and industry vertical is Virion Serion in?

Virion Serion is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Virion Serion

Who are the top strategic acquirers in Virion Serion's sector and industry

Top strategic M&A buyers and acquirers in Virion Serion's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Virion Serion?

Top strategic M&A buyers groups and sectors for Virion Serion include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Virion Serion's sector and industry vertical

Which are the top PE firms investing in Virion Serion's sector and industry vertical?

Top PE firms investing in Virion Serion's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Virion Serion's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Virion Serion's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Virion Serion's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Virion Serion include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Virion Serion's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Virion Serion?

The key public trading comparables and valuation benchmarks for Virion Serion include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Virion Serion for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Virion Serion with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Virion Serion's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Virion Serion with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Virion Serion's' sector and industry vertical?

Access recent funding rounds and capital raises in Virion Serion's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Virion Serion